• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Identification and characterization of a novel antigenic epitope in the hemagglutinin of the escape mutants of H9N2 avian influenza viruses

tetano

Editor, Senior Moderator
Vet Microbiol. 2015 Apr 23. pii: S0378-1135(15)00157-1. doi: 10.1016/j.vetmic.2015.04.012. [Epub ahead of print]
[h=1]Identification and characterization of a novel antigenic epitope in the hemagglutinin of the escape mutants of H9N2 avian influenza viruses.[/h] Zhu Y[SUP]1[/SUP], Yang D[SUP]1[/SUP], Ren Q[SUP]1[/SUP], Yang Y[SUP]1[/SUP], Liu X[SUP]1[/SUP], Xu X[SUP]1[/SUP], Liu W[SUP]2[/SUP], Chen S[SUP]3[/SUP], Peng D[SUP]4[/SUP], Liu X[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] H9N2 avian influenza virus (AIV) evolves rapidly in both genovariation and antigenicity. It is essential to monitor the change of antigenicity, in particular in the hemagglutinin (HA) protein. Here we reported the selection of antigenic variants from A/Chicken/Shanghai/F/98 (H9N2) and A/chicken/Taixing/10/2010 (H9N2) viruses using HA-specific monoclonal antibodies (MAbs). Based on the reactivity of these variant and wild-type strains with the MAbs, we identified 6 critical amino acid positions (92, 145, 166, 167, 168, and 197) in the H9 antigenic sites, including the position 92 that has never been reported. Among AIVs originated from chicken in mainland China, the rates of Gly and Arg at position 92 within BJ/94-like (A/chicken/Beijing/1/1994) lineage viruses were 62.2% (28/45) and 37.8% (17/45), respectively; whereas the rates of Gly and Arg at position 92 within Y280-like (A/duck/Hong Kong/Y280/97) lineage viruses were 0.3% (2/670) and 99.1% (673/679), respectively. Our study suggests that G92R mutation together with other identified antigenic sites may serve as molecular markers for H9N2 virus evolution, and may aid improving AIV vaccine effectiveness.
Copyright ? 2015 Elsevier B.V. All rights reserved.


[h=4]KEYWORDS:[/h] Antigenic site; H9N2 avian influenza viruses; Hemagglutinin; Monoclonal antibodies

PMID: 25934533 [PubMed - as supplied by publisher]
 
Back
Top Bottom